Fate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke?
Mesenchymal stem cells (MSCs) are believed to be promising for cell administration therapy after ischemic stroke. Because of their advantageous characteristics, such as ability of differentiation into neurovascular lineages, avoidance of immunological problems, and abundance of graft cells in mesode...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204523/ https://www.ncbi.nlm.nih.gov/pubmed/25374506 http://dx.doi.org/10.3389/fncel.2014.00322 |